Literature DB >> 18761703

Identification of Helicobacter pylori infected patients, using administrative data.

S Thirumurthi1, R Desilva, D L Castillo, P Richardson, N S Abraham.   

Abstract

BACKGROUND: Helicobacter pylori is a prevalent organism implicated in peptic ulcer disease. AIM: To validate administrative data for diagnosis of H. pylori-infected patients.
METHODS: Administrative data identified patients with ICD-9 code for H. pylori (041.86) or prescription of eradication therapy; diagnosis was confirmed by chart abstraction. Multivariable regression assessed predictors of infection considering drug therapy, ICD-9 code 041.86, procedure code, in-patient or out-patient diagnostic code, age, gender and race to generate an algorithm for validation.
RESULTS: The test cohort of 531 patients (361 potential cases; 170 random controls) was primarily male (94%), Caucasian (59%) and elderly [67 years (s.d. 10)]. The positive predictive value (PPV) of ICD-9 code 041.86 was 100% and 97.4% if from an in-patient or out-patient encounter, respectively. Eradication drug therapy had a PPV of 73.7% (triple therapy) and 97.7% (quadruple therapy). The strongest predictors were out-patient ICD-9 code 041.86 (OR 8.1; 95% CI: 7.0-9.1); eradication drug therapy (OR 7.4; 95% CI: 6.6-8.3); oesophagogastroduodenoscopy (OR 3.5; 95% CI: 3.3-3.6); and age > or =70 (OR 1.2; 95% CI: 1.1-1.4). An algorithm including these data elements yielded a c-statistic of 0.93 and PPV of 97.9%.
CONCLUSIONS: Administrative data can diagnose H. pylori-infected patients. The diagnostic algorithm includes presence of eradication drug therapy overlapping with an out-patient ICD-9 code 041.86 among elderly adults.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18761703     DOI: 10.1111/j.1365-2036.2008.03845.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  6 in total

1.  A Comparison of Logistic Regression Against Machine Learning Algorithms for Gastric Cancer Risk Prediction Within Real-World Clinical Data Streams.

Authors:  Robert J Huang; Nicole Sung-Eun Kwon; Yutaka Tomizawa; Alyssa Y Choi; Tina Hernandez-Boussard; Joo Ha Hwang
Journal:  JCO Clin Cancer Inform       Date:  2022-06

2.  Risk Factors and Incidence of Gastric Cancer After Detection of Helicobacter pylori Infection: A Large Cohort Study.

Authors:  Shria Kumar; David C Metz; Susan Ellenberg; David E Kaplan; David S Goldberg
Journal:  Gastroenterology       Date:  2019-10-22       Impact factor: 22.682

3.  Validation of ICD-9-CM diagnostic codes for inflammatory bowel disease among veterans.

Authors:  Selvi Thirumurthi; Reezwana Chowdhury; Peter Richardson; Neena S Abraham
Journal:  Dig Dis Sci       Date:  2009-12-24       Impact factor: 3.199

4.  Ranitidine Use and Gastric Cancer Among Persons with Helicobacter pylori.

Authors:  Shria Kumar; David S Goldberg; David E Kaplan
Journal:  Dig Dis Sci       Date:  2021-04-15       Impact factor: 3.199

5.  The association of Helicobacter pylori with pancreatic cancer.

Authors:  Shria Kumar; David C Metz; David E Kaplan; David S Goldberg
Journal:  GastroHep       Date:  2020-05-05

6.  The epidemiology, diagnosis, and cost of dyspepsia and Helicobacter pylori gastritis: a case-control analysis in the Southwestern United States.

Authors:  Douglas Mapel; Melissa Roberts; Andrew Overhiser; Andrew Mason
Journal:  Helicobacter       Date:  2012-09-04       Impact factor: 5.753

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.